IOVA Iovance Biotherapeutics Inc

Lion Biotechnologies Inc is a biopharmaceutical company in the United States. Its lead pipeline candidate, LN-144, uses the tumor-infiltrating lymphocytes to treat serious diseases.

$6.85  +0.44 (6.86%)
As of 12/02/2022 15:59:58 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/26/2010
Outstanding shares:  157,840,581
Average volume:  4,846,003
Market cap:   $1,011,758,124
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BF0DMK7
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   1.95
PS ratio:   0.00
Return on equity:   -64.93%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy